Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГБОУ ВО «Дальневосточный государственный медицинский университет» Минздрава России, Хабаровск, Россия typ50@rambler.ru
Список исп. литературыСкрыть список 1. Организация оказания медицинской помощи беременным, роженицам, родильницам и новорожденным при новой коронавирусной инфекции COVID-19. Методические рекомендации. Минздрав России (Версия 4 от 05.07.2021). М., 2021. [Organization of medical care for pregnant women. to women in childbirth, postpartum women and newborns with a new coronavirus infection COVID-19. Methodical recommendations. Ministry of Health of Russia. Version 4, 07/05/2021. Moscow, 2021) (in Russian).] 2. Alviggi Carlo et al. COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management. Reprod Biol Endocrinol 2020; 18 (1): 1–7. 3. Vaiarelli Alberto et al. COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine. Reproductive Biomed Online 2020; 40 (6): 755–9. 4. https://www.who.int/emergencies/diseases/novel-coronavirus 2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19-contraception-and-family-planning 5. Xie Yuanliang et al. COVID-19 complicated by acute pulmonary embolism. Radiology: Cardiothoracic Imaging 2020; 2 (2): e200067. 6. Li Taisheng, Hongzhou Lu, Wenhong Zhang. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect 2020; 9 (1): 687–90. 7. https://www.medvedomosti.media/articles/kontratseptsiya-v-period-pandemii-covid-19-rekomendatsii-voz/ 8. Cagnacci A, Xholli A. Age-related difference in the rate of coronavirus disease 2019 mortality in women versus men. Am J Obstetrics Gynecol 2020; 223 (3): 453–4. DOI: 10.1016/j.ajog.2020.05.039 9. Al-Lami RA, Urban RJ, Volpi E et al. Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19). Mayo Clinic Proceedings 2020; 95 (8): 1710–4. DOI: 10.1016/j.mayocp.2020.05.013 10. Sutton D, Fuchs K, D’Alton M, Goffman D. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery. New Eng J Med 2020; 382 (22): 2163–4. DOI: 10.1056/NEJMc2009316 11. Mauvais-Jarvis F, Klein SL, Levin ER. Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes. Endocrinology 2020; 1; 161 (9): bqaa127. DOI: 10.1210/endocr/bqaa127 12. Suba Z. Prevention and therapy of COVID-19 via exogenous estrogen and Pharmaceutical Sci 2020; 23 (1): 75–85. DOI: 10.18433/ jpps31069 13. Costerira R, Murray B, Christiansen C et al. Estrogen and COVID-19 symptoms: associations in women from the COVID Symptom Study. MedRxiv – the preprint server for Health Sciences. 2020. DOI: 10.1101/2020.07.30.20164921 14. Мареев В.Ю., Орлова Я.А., Павликова Е.П. и др. Возможности комбинированной терапии на раннем этапе течения новой коронавирусной инфекции (COVID-19). Разбор клинических случаев и дизайн исследования: Бромгексин и Спиронолактон для лечения коронавирусной инфекции, требующей госпитализации (БИСКВИТ). ISSN 0022-9040. Кардиология. 2020; 60 (8). DOI: 10.18087/cardio.2020.8.n1307 [Mareev V.Yu., Orlova Ya.A., Pavlikova E.P. et al. Possibilities of combination therapy at an early stage of the course of novel coronavirus infection (COVID-19). Case Study and Study Design: Bromhexine and Spironolactone for the Treatment of Corona Viral Infection Requiring Hospitalization (BISQUIT). ISSN 0022-9040. Cardiology. 2020; 60 (8). DOI: 10.18087/cardio.2020.8.n1307 (in Russian).] 15. Muhn Р, Fuhrmann U, Fritzemeier KH et al. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Ann NY Acad Sci 1995; 761: 311–35.